Skip to content

APOTHEEK DE LIEVE

Active
Private limited companyfounded 2008active for 17 yearsGrote Baan 291, 9930 Lievegem, BelgiumKBO/BCE: BE 0808.285.756
Summary

APOTHEEK DE LIEVE has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €141,550 and a net result of -€18,173. Equity is growing by about 12% per year across the filed financial years. Its solvency ranks better than 56% of 543 sector peers (NACE 47, financial year 2026). The computed 12-month bankruptcy probability is 0.4% (very low).

Risk analysisFollow ReportCompare
APOTHEEK DE LIEVEActiveChecked score 82/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€383,620total assets 2025
Equity
€141,550
Loss
-€18,173
Turnover not published (abbreviated or micro format)
Financial health
82 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.4%
Structure
Parent
RIJCKAERT INVEST · 100%
  • RIJCKAERT INVESTDirector · permanent representative Rijckaert Lien
2025 accounts 50 days early1 of 5 deeds summarised
Why 82raises riskFigures for financial year 2025 (filed 11-09-2025)lowers riskSize: total assets €383,620Liquidity: current ratio 1.16, cash €79,188Founded in 2008Show the evidence

Checked score

Score 2025
82 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 35% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Weak
Solvency 62-20
equity 36.9% of total assets
Liquidity 44-6
short-term debt 61.2% · cash 20.6%
Profitability 13=
return on assets -4.7%
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,263 companies, NACE 47, micro)
Last 24 months 11-2024: 0.5% 12-2024: 0.5%● unchanged vs 11-2024 01-2025: 0.5%● unchanged vs 12-2024 02-2025: 0.5%● unchanged vs 01-2025 03-2025: 0.5%● unchanged vs 02-2025 04-2025: 0.5%● unchanged vs 03-2025 05-2025: 0.5%● unchanged vs 04-2025 06-2025: 0.5%● unchanged vs 05-2025 07-2025: 0.6%▲ +0.1 percentage points vs 06-2025 08-2025: 0.7%▲ +0.1 percentage points vs 07-2025highest value 09-2025: 0.7%● unchanged vs 08-2025 10-2025: 0.5%▼ -0.2 percentage points vs 09-2025 11-2025: 0.5%● unchanged vs 10-2025 12-2025: 0.5%● unchanged vs 11-2025 01-2026: 0.5%● unchanged vs 12-2025 02-2026: 0.5%● unchanged vs 01-2026 03-2026: 0.5%● unchanged vs 02-2026 04-2026: 0.5%● unchanged vs 03-2026 05-2026: 0.2%▼ -0.3 percentage points vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026lowest value 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.4%▲ +0.2 percentage points vs 09-2026
Credit of up to €11,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.16, compared with 1.79 in 2024, below the usual 1.5; short-term debt: 61.2% and cash: 20.6% of total assets), and 63.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 52% on solvency, 42% on liquidity, 19% on profitability and 25% on growth.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €383,620
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Figures for financial year 2025 (filed 11-09-2025)
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.16, cash €79,188
NBB · annual accounts
lowers risk · Founded in 2008
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
19202122232425
2019 to 2025 · latest year -€18,173
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 11-09-2025, 50 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
50 days early
2024
1 day early
2023
1 day early
2022
4 days late
2021
3 days early
2020
53 days early
2019
51 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 22 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 31-03-2026 is due by 31-10-2026. Nothing is late today. The company usually files around 30 October (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
31-03-2026 year end30-10-2026 today31-10-2026 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Weakest financial yearnet -€18,173
  3. Annual accounts filedfinancial year 2024 · abbreviated…

Key points

  • Controlled by RIJCKAERT INVEST 100% View
  • Caution: 2 loss-making years in a rowloss financial year 2025 -€18,173 View
  • One director decidessole director in office 1 View

By topic

Financials

Financial year
2025
Total assets
€383,620
Loss
-€18,173
Solvency
36.9%
Total assets▲ 36.1%
Net result
20192025
Go to Financials

Timeline

Events
22
Since
2010
Next accounts
by 31-10-2026
  1. 22-04-2024Resignation: RIJCKAERT INVEST (niet statutair zaakvoerder)
  2. 30-10-2023Annual accounts filed
  3. 04-11-2022Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
09-12-2008
Year ends
31-03
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
36
Purpose
“Het oprichten,overnemen en uitbaten van apotheken,aankoop- en verkoop,in- en…” (deed in Dutch)
Go to Articles of association

Key facts about APOTHEEK DE LIEVE

What is the company number of APOTHEEK DE LIEVE?
0808.285.756. In Belgium the VAT number is the company number with BE in front: BE 0808.285.756.
Where is APOTHEEK DE LIEVE based?
The registered office is at Grote Baan 291, 9930 Lievegem.Company details
What does APOTHEEK DE LIEVE do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK DE LIEVE?
Private limited company (BV).
When was APOTHEEK DE LIEVE founded?
On 09-12-2008.
Is APOTHEEK DE LIEVE still active?
Yes, APOTHEEK DE LIEVE is an active enterprise in the KBO register.
What is the turnover of APOTHEEK DE LIEVE?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is APOTHEEK DE LIEVE profitable?
In financial year 2025, APOTHEEK DE LIEVE made a loss of €18,173.
Where can I find the annual accounts of APOTHEEK DE LIEVE?
APOTHEEK DE LIEVE filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK DE LIEVE due?
By 31-10-2026, for financial year 2026.Timeline

Companies related to APOTHEEK DE LIEVE

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure